Maintain
~50%
of patients are expected to have a low-risk score
Patients are likely to have stable kidney function over the next five years
Follow up at least annually
Monitor
~35%
of patients are expected to have an intermediate-risk score
Patients are at an average risk for progression to ESKD
May need modification and a specialist consultation
Follow-up at least 2x year
Act
~15%
of patients are expected to have a high-risk score
Patients at elevated risk for progression to ESKD
Will require aggressive lifestyle changes, medication management and specialist referrals
Plus, real-world evidence demonstrates that
PCPs want this tool.
98%
Percentage of PCPs who would adopt KidneyIntelX to identify adult patients with type 2 diabetes and CKD who are at risk of accelerated kidney function decline
2X
More likely to appropriately prescribe SGLT2 inhibitors (SGLT2i) and angiotensin II receptor blockers (ARB) for their high-risk patients
Nearly 3X
More likely to appropriately refer their high-risk patients to a specialist